Biokin/BMS’s Iza-bren Hits First Phase III OS Endpoint, Albeit In China

 
• By Dexter Jie Yan
  
Esophageal_Cancer
Before the latest announcement, iza-bren had yet to deliver any significant overall survival benefit in any cancer types. • Source: Shutterstock

More from Clinical Trials

More from Immuno-oncology